Cargando…
Selective Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 for Patients With Metabolic Syndrome: Is the Target Liver, Fat, or Both?
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
American Diabetes Association
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2606863/ https://www.ncbi.nlm.nih.gov/pubmed/19114723 http://dx.doi.org/10.2337/db08-1404 |
| _version_ | 1782162999194157056 |
|---|---|
| author | Stewart, Paul M. Tomlinson, Jeremy W. |
| author_facet | Stewart, Paul M. Tomlinson, Jeremy W. |
| author_sort | Stewart, Paul M. |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-2606863 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2009 |
| publisher | American Diabetes Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-26068632010-01-01 Selective Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 for Patients With Metabolic Syndrome: Is the Target Liver, Fat, or Both? Stewart, Paul M. Tomlinson, Jeremy W. Diabetes Commentaries American Diabetes Association 2009-01 /pmc/articles/PMC2606863/ /pubmed/19114723 http://dx.doi.org/10.2337/db08-1404 Text en Copyright © 2009, American Diabetes Association Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
| spellingShingle | Commentaries Stewart, Paul M. Tomlinson, Jeremy W. Selective Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 for Patients With Metabolic Syndrome: Is the Target Liver, Fat, or Both? |
| title | Selective Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 for Patients With Metabolic Syndrome: Is the Target Liver, Fat, or Both? |
| title_full | Selective Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 for Patients With Metabolic Syndrome: Is the Target Liver, Fat, or Both? |
| title_fullStr | Selective Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 for Patients With Metabolic Syndrome: Is the Target Liver, Fat, or Both? |
| title_full_unstemmed | Selective Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 for Patients With Metabolic Syndrome: Is the Target Liver, Fat, or Both? |
| title_short | Selective Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 for Patients With Metabolic Syndrome: Is the Target Liver, Fat, or Both? |
| title_sort | selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1 for patients with metabolic syndrome: is the target liver, fat, or both? |
| topic | Commentaries |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2606863/ https://www.ncbi.nlm.nih.gov/pubmed/19114723 http://dx.doi.org/10.2337/db08-1404 |
| work_keys_str_mv | AT stewartpaulm selectiveinhibitorsof11bhydroxysteroiddehydrogenasetype1forpatientswithmetabolicsyndromeisthetargetliverfatorboth AT tomlinsonjeremyw selectiveinhibitorsof11bhydroxysteroiddehydrogenasetype1forpatientswithmetabolicsyndromeisthetargetliverfatorboth |